Blog
Amended FRE 702 on Expert Testimony Effective December 1, 2023
Read moreBlog
Amended FRE 702 on Expert Testimony Effective December 1, 2023
Read moreWebinar
FTC Challenges to Orange Book Listings: Considerations for Patent Holders
Read moreArticle
Strategic Use of Evidence at the Patent Trial and Appeal Board
Read moreBlog
Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book
Read moreBlog
District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs
Read moreBlog
ITC Monthly Wrap-Up: November 2023
Read moreBlog
Minnesota Patent Litigation Wrap-Up: Q3 2023
Read more